The phrase not losing weight can describe everything from a slow start to normal pauses and longer-term stalls, and those differences matter
People taking a GLP-1 medication like Ozempic often report side effects like stomach issues, loss of appetite, dizziness, or headaches
Is it rooted in health concerns, eating disorder thoughts, or internalized weight stigma
Eating behaviorincluding meal timing, food reward, satiety responsiveness, and even mindful eatingcan impact the release and activity of GLP-1 (Huber et al 2024)
Mechanistically, semaglutide monotherapy suppressed mitochondrial gene expression and elevated atrophy-related genes
GLP-1 receptor agonists are large, water-loving peptides, and the skin's outer barrier is built to block exactly those molecules